Key Highlights
- Texas Instruments exceeded Q1 2026 projections with earnings per share of $1.68 compared to consensus estimates of $1.36
- Quarterly revenue reached $4.83 billion, surpassing Wall Street’s forecast of $4.52 billion
- Industrial business expanded over 20% sequentially; Data Center operations climbed more than 25%
- Barclays lifted TXN rating to Equalweight from Underweight, increasing price target from $175 to $250
- Several Wall Street firms boosted targets, with KeyBanc reaching $325 and Rosenblatt hitting $330
Texas Instruments delivered impressive first-quarter 2026 results, surpassing Wall Street projections across key metrics. Earnings per share reached $1.68, significantly exceeding the $1.36 analyst consensus. Quarterly revenue totaled $4.83 billion compared to expectations of $4.52 billion.
Shares rallied approximately 16% following the announcement, climbing from roughly $233 to around $274.
Texas Instruments Incorporated, TXN
The outperformance stemmed from robust momentum in two critical business segments: Industrial and Data Center. The Industrial division expanded more than 20% sequentially in March. Meanwhile, Data Center operations surged over 25% during the same timeframe.
Management’s second-quarter outlook exceeded typical seasonal patterns, suggesting sustained momentum in both segments. Automotive demand continued showing volatility, according to UBS analysts.
Wall Street Responds with Upgrades and Higher Targets
Barclays delivered the most significant rating change, elevating TXN from Underweight to Equalweight while boosting its price objective from $175 to $250. The investment bank cited enhanced fundamentals in Industrial and Data Center markets as justification for the revision.
Barclays projects Data Center revenue to expand over 90% throughout calendar year 2026. The firm also anticipates Industrial performance will exceed seasonal norms again in June.
The investment bank now forecasts $10 per share in free cash flow for TXN during 2027. This projection compares favorably to the current Street consensus of approximately $8.55.
UBS maintained its Buy recommendation while lifting its price objective from $260 to $295. The firm noted results aligned with heightened expectations, while guidance provided a modest upside surprise.
Cantor Fitzgerald increased its target from $250 to $280 while maintaining a Neutral stance. The firm applied an elevated 28x valuation multiple versus its prior 25x framework, reflecting strengthening trends across analog semiconductor markets.
Broader Analyst Community Turns More Bullish
KeyBanc established the highest Street target, pushing it to $325. BofA Securities upgraded TXN to Buy with a $320 objective, highlighting momentum in aerospace and defense applications within industrial markets.
Rosenblatt Securities boosted its target to $330. Baird elevated its forecast to $300. Wolfe Research, which observed Q1 revenue increased 9% sequentially, established a $315 target.
TXN currently commands approximately 26 times free cash flow, representing a premium to its historical mid-teens valuation range. The stock’s price-to-earnings ratio stands at 43.15.
Barclays cautioned that management still faces execution challenges regarding consensus estimates for the second half. Cantor Fitzgerald also highlighted potential headwinds from memory supply constraints and geopolitical uncertainties as reasons for maintaining selectivity within the broader semiconductor sector.
The stock was changing hands near $274, approaching its previous 52-week peak of $238.80 established before the earnings-driven surge.


